Hair Loss Treatment
According to the American Hair Loss Association, two-thirds of men experience some sort of hair loss by the age of 35. Hundreds of products have claims to stop various kinds of hair loss but only two products have been FDA approved and clinically proven to have an effect on hair loss. Now, Shiseido, Japanese cosmetics and personal care company, is claiming they have an effective treatment for baldness and they seem to have the research to support it.
Shiseido opened a research facility in 2014, for the purpose of developing regenerative medicine for hair loss. In collaboration with a Canadian bio-venture company, RepliCel, they have been exclusively developing what is known as RepliCel Hair-01 (RCH-01) hair regeneration technology. RCH-01 is “autologous cell transplantation technology” in which dermal sheath cup cells, considered to promote hair growth, are targeted and cultured. The cells are then injected into the patient’s balding areas, stimulating the hair follicles and promoting new hair growth. The company has announced successfully safe trials and are in the midst of phase 2 of trials to further test effectiveness.
The Next Wave of Regenerative Medicine
Currently, the treatment cannot be applied to women which is a significant area to be developed. The results of the trials will reveal if this really is the next wave of regenerative medicine. Japan has been regarded as a world leader in regenerative medicine and international collaborations like this are poised to develop treatments quickly and potentially effectively as well.